RBR-6ws3m6尚未招募未知
Evaluation of a health product for the prevention of burns under normal conditions of use.
Ipclin - Pesquisa Clínica Integrada0 个研究点开始时间: 2019年6月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 65Y(—)
入选标准
- •Age from 18 to 65 years. Gender: male or female. All phototypes. Skin integrity in the test area, selected by the dermatologist, except for possible grade I or II skin burn resulting from radiotherapy. Participants who have given their free and informed consent, are cooperative and aware of the necessity and duration of the controls, so that a perfect adherence to the protocol can be expected. Participants able to read and understand the documents delivered (information leaflet and consent form) and what is explained to them. Participants who agree not to apply any other cosmetic products on the face during the study period, except for the research product and usual hygiene products.
排除标准
- •Pregnancy or lactation;
- •Pregnancy or lactation. Skinmarks in the test region that interfere with the evaluation of possible skin reactions (pigmentation disorders, vascular malformations, scars, increased hairiness, ephelides and nevus in large numbers). Participant with skin problem, in particular: urticaria, edema, eczema, recurrent herpes, herpes zoster occurred in the last 3 months, polycythemia, common acne with onset of nodules or cysts, psoriasis, ichthyosis, lichen planus, lupus, hyperhidrosis. Active dermatoses (local or disseminated) that may interfere with the study results. History of allergic or irritant reactions to topical products: medicines, cosmetics or health correlates of the same category (or other category, but which the investigator considers relevant). History of intense discomfort sensations to topical products: medicines, cosmetics or health correlates of the same category (or other category, but which the researcher considers relevant). Be participating or have participated in another clinical study completed less than 14 days prior to the selection. Any previously unquoted condition which, in the opinion of the investigator, could jeopardize the evaluation of the study;
- •History of absence of adherence or unwillingness to adhere to the study protocol. Professionals directly involved in the realization of this protocol and their relatives.
研究者
相似试验
已完成
不适用
A clinical study to evaluate the preventive effect of denosumab(Pralia) on bone loss in men receiving androgen-deprivation therapy for prostate cancer.Prostate cancerJPRN-UMIN000015127Department of Urology, Keio University School of Medicine40
尚未招募
Unknown
A study to evaluate efficacy and safety of Anti-pollution product.CTRI/2024/08/072157Zydus Wellness Products Limited
尚未招募
Unknown
A study to evaluate efficacy & safety of Anti-pollution product.CTRI/2024/08/071927Zydus Wellness Products Limited
尚未招募
Unknown
A study to evaluate efficacy and safety of Anti-pollution productCTRI/2024/08/072156Zydus Wellness Products Limited
已完成
2 期
Effect of pilocarpin on xerostomialarynx, Hypopharynx, Nasopharynx.Malignant neoplasm of larynx, Malignant neoplasm of hypopharynx, Malignant of nasopharynxc11?c13?c3IRCT2014042013167N2Shahid Sadoughi University of Medical Sciences34
